Science Explorer Back to mapMap

Most cited papers from Mesothelioma Applied Research Foundation

What are the most cited papers from Mesothelioma Applied Research Foundation?

The most cited paper from Mesothelioma Applied Research Foundation is "Germline BAP1 mutations predispose to malignant mesothelioma" (Joseph R. Testa, Mitchell Cheung, Jianming Pei et al., 2011), with 1,088 citations. Next come "Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy" (157) and "Transcriptome sequencing of malignant pleural mesothelioma tumors" (156).

Showing 49 of 49 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Germline BAP1 mutations predispose to malignant mesothelioma Joseph R. Testa, Mitchell Cheung, Jianming Pei et al. · Nature Genetics Open access 28 Aug 2011 1,088
2 Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy Raffit Hassan et al. · Proceedings of the National Academy of Sciences Open access 11 Apr 2019 157
3 Transcriptome sequencing of malignant pleural mesothelioma tumors David J. Sugarbaker, William G. Richards, Gavin J. Gordon et al. · Proceedings of the National Academy of Sciences Open access 26 Feb 2008 156
4 Consensus Report of the 2015 Weinman International Conference on Mesothelioma Michele Carbone et al. · Journal of Thoracic Oncology Open access 22 Jul 2016 146
5 Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation Anne S. Tsao et al. · Journal of Thoracic Oncology Open access 25 Sep 2018 123
6 Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer Jill A. Ohar, Mitchell Cheung, Jacqueline N. Talarchek et al. · Cancer Research Open access 11 Jan 2016 107
7 Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations Michele Carbone et al. · Journal of Thoracic Oncology Open access 21 Apr 2022 96
8 Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s Michele Carbone et al. · PLoS Genetics Open access 18 Dec 2015 90
9 The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation Daniel Richard Gomez, Andreas Rimner, Charles B. Simone et al. · Journal of Thoracic Oncology Open access 22 May 2019 75
10 Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy Paul Hendrick Sugarbaker, Kiran Kalyan Turaga, H. Richard Alexander et al. · Journal of Oncology Practice Oct 2016 61
11 Treatment of Pleural Mesothelioma: ASCO Guideline Update Hedy Lee Kindler et al. · Journal of Clinical Oncology 8 Jan 2025 59
12 Chemotherapy-Induced Immunomodulation in Non-Small-Cell Lung Cancer: A Rationale for Combination Chemoimmunotherapy Hua Zheng, Masha Zeltsman, Marjorie Glass Zauderer et al. · Immunotherapy Open access Sep 2017 55
13 Changing Pattern in Malignant Mesothelioma Survival Jennifer Faig, Suzanne E. Howard, Edward Allen Levine et al. · Translational Oncology Open access Feb 2015 51
14 Peritoneal Mesothelioma Mary E. Hesdorffer, J. Chabot, Carolyn M. DeRosa et al. · Current Treatment Options in Oncology Jun 2008 43
15 Role of asbestos clearance in explaining long-term risk of pleural and peritoneal cancer: a pooled analysis of cohort studies Francesco Barone‐Adesi et al. · Occupational and Environmental Medicine Open access 14 Aug 2019 35
16 Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee – International Association for the Study of Lung Cancer – Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting Ritu R. Gill et al. · Journal of Thoracic Oncology Open access 27 Aug 2019 25
17 Asbestos fibers in the gallbladder of patients affected by benign biliary tract diseases Federica Grosso, Lorenza Randi, Alessandro Croce et al. · European Journal of Gastroenterology & Hepatology 8 Apr 2015 20
18 SV40, JC and BK expression in tissue, urine and blood samples from patients with malignant and nonmalignant pleural disease. Luigi Strizzi, Giovina Vianale, Mariateresa Giuliano et al. · PubMed Jun 2000 19
19 Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma Michelle S. Boyar, Mary E. Hesdorffer, Mary Louise Keohan et al. · Sarcoma Open access 2008 19
20 Workshop summary: Potential usefulness and feasibility of a US National Mesothelioma Registry Kristin J. Cummings, Michael John Becich, David J. Blackley et al. · American Journal of Industrial Medicine Open access 19 Nov 2019 17
21 Pathologic Considerations and Standardization in Mesothelioma Clinical Trials Ming‐Sound Tsao et al. · Journal of Thoracic Oncology Open access 28 Jun 2019 15
22 Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma Yi Zhuo, Lanying Lin, Shushan Wei et al. · Medicine Open access Dec 2016 15
23 Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1 Hue Tu Quach, Zhaohua Hou, Rebecca Y. Bellis et al. · Expert Opinion on Investigational Drugs Open access 2 Nov 2022 7
24 The diagnosis of mesothelioma by panels W. McCaughey · American Journal of Industrial Medicine 1991 7
25 Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres Dean Anthony Fennell, Daniel E. Griffiths, Zina B. Eminton et al. · BMJ Open Open access Nov 2023 5
26 Approach to offering remote support to mesothelioma patients: the mesothelioma survivor project Gleneara Elizabeth Bates, Anisah Khurshid Hashmi, Toby Bressler et al. · Translational Lung Cancer Research Open access Jun 2016 4
27 Mesothelioma survivorship: challenges in delivering quality care Gleneara Elizabeth Bates, Jadmin L. Mostel, Mary E. Hesdorffer · Expert Review of Quality of Life in Cancer Care 4 May 2017 2
28 Malignant pleural mesothelioma Mary E. Hesdorffer, Joshua Leinwand, Taub Rn · The Journal of the Royal College of Physicians of Edinburgh Sep 2007 1
29 Association of Age with Perceived Economic Deprivation in Mesothelioma Patients -Focusing on Changes in Employment Status- Taiki Fukujin, Sayuri Kageyama, Kanako Komaru et al. · Haigan Open access 20 Oct 2023 1
30 OA17.04 The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers Matthew Paul Smeltzer et al. · Journal of Thoracic Oncology Open access Oct 2021 1
31 Challenges Facing Mesothelioma Patients and Their Families: Medical/Legal Intersections Kirk Hartley, Mary E. Hesdorffer · Current cancer research Book chapter 2017 1
32 97 Bridging the Gap: Enhancing Continuity of Care Through Cross-Site Working by the Mesothelioma UK Clinical Nurse Specialist Slaven Kate · Lung Cancer Feb 2026 0
33 99 Cough and mesothelioma (CAM): Recommendations from a qualitative study exploring the impact of cough on quality of life for patients with mesothelioma and their caregivers Slaven Kate · Lung Cancer Feb 2026 0
34 98 Advance care planning in mesothelioma: a scoping review Sarah Hargreaves, Clare Gardiner, Jeff Morgan et al. · Lung Cancer Feb 2026 0
35 108 Assessing outcomes in patients receiving Immunotherapy for Mesothelioma using Real-World Data (AIM-RWD) - results from a single-centre pilot study Emilia Postaleniec, Jay Panchal, Sean Dulloo et al. · Lung Cancer Feb 2026 0
36 Understanding the Mesothelioma Journey from Diagnosis through Bereavement Amanda Toler Woodward, Jenavry Hirsch, Xuehan Zhang et al. · Innovation in Aging Open access Dec 2025 0
37 77 Understanding barriers and facilitators to receiving systemic anti-cancer treatment (SACT) for mesothelioma patients Taylor Bethany, Drury Jenna, Hargreaves Sarah et al. · Lung Cancer Feb 2025 0
38 PARTNERING WITH COMMUNITY ON A SUCCESSFUL FEDERAL FUNDING APPLICATION FOR MESOTHELIOMA CAREGIVERS Amanda Toler Woodward, Maria Towe, Jen Hirsch et al. · Innovation in Aging Open access Dec 2024 0
39 Utilization of the Consultation and Support Department in Application for Industrial Accident Compensation Insurance System for Patients Who Develop Mesothelioma Taiki Fukujin, Sayuri Kageyama, Kanako Komaru et al. · Haigan Open access 20 Feb 2023 0
40 Role and Issues of Physicians in Industrial Accident Compensation Insurance System for Mesothelioma Development Taiki Fukujin, Sayuri Kageyama, Kanako Komaru et al. · Haigan Open access 20 Dec 2022 0
41 Inadequate Nutrition Services in Outpatient Cancer Centers (P05-036-19) Elaine B. Trujillo, Katrina Claghorn, Suzanne Dixon et al. · Current Developments in Nutrition Open access Jun 2019 0
42 Occupational Therapy and Mesothelioma Rodney Hemingway Book chapter 2019 0
43 The Impact of the Internet on Mesothelioma Patients: The Good, the Bad, and the Ugly Maja Belamaric, Mary E. Hesdorffer Book chapter 2019 0
44 Chemotherapy and Standard Treatment Options Mary E. Hesdorffer, Gleneara E. Bates-Pappas Book chapter 2019 0
45 P1.10-007 Preparing Mesothelioma Patients for Treatment: Providing Psychosocial Support Networks Gleneara Elizabeth Bates, Jadmin L. Mostel, Mary E. Hesdorffer · Journal of Thoracic Oncology Open access Nov 2017 0
46 ES 03.04 Mesothelioma: Beyond the Basics Mary E. Hesdorffer, Gleneara Elizabeth Bates · Journal of Thoracic Oncology Open access Nov 2017 0
47 MA 04.05 The Impact of the Meso Foundation on Advocacy Efforts for Funding Mesothelioma Research Gleneara Elizabeth Bates, Jadmin L. Mostel, Mary E. Hesdorffer · Journal of Thoracic Oncology Open access Nov 2017 0
48 Mesothelioma Research as a Social Issue Christopher E. Hahn · Inhalation Toxicology 2006 0
49 Tips for Palliative Care Professionals Treating Mesothelioma Patients Michelle Y. Llamas · Journal of Palliative Medicine Nov 2012 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.